276 related articles for article (PubMed ID: 23023736)
1. Wiskott-Aldrich syndrome presenting with a clinical picture mimicking juvenile myelomonocytic leukaemia.
Yoshimi A; Kamachi Y; Imai K; Watanabe N; Nakadate H; Kanazawa T; Ozono S; Kobayashi R; Yoshida M; Kobayashi C; Hama A; Muramatsu H; Sasahara Y; Jakob M; Morio T; Ehl S; Manabe A; Niemeyer C; Kojima S
Pediatr Blood Cancer; 2013 May; 60(5):836-41. PubMed ID: 23023736
[TBL] [Abstract][Full Text] [Related]
2. Wiskott-Aldrich syndrome with unusual clinical features similar to juvenile myelomonocytic leukemia.
Sano H; Kobayashi R; Suzuki D; Yasuda K; Nakanishi M; Nagashima T; Yamada M; Kobayashi K
Int J Hematol; 2012 Aug; 96(2):279-83. PubMed ID: 22736231
[TBL] [Abstract][Full Text] [Related]
3. Wiskott-Aldrich syndrome is an important differential diagnosis in male infants with juvenile myelomonocytic leukemialike features.
Watanabe N; Yoshimi A; Kamachi Y; Kawabe T; Muramatsu H; Matsumoto K; Manabe A; Kojima S; Kato K
J Pediatr Hematol Oncol; 2007 Dec; 29(12):836-8. PubMed ID: 18090932
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutations activating Wiskott-Aldrich syndrome protein concomitant with RAS pathway mutations in juvenile myelomonocytic leukemia patients.
Coppe A; Nogara L; Pizzuto MS; Cani A; Cesaro S; Masetti R; Locatelli F; Te Kronnie G; Basso G; Bortoluzzi S; Bresolin S
Hum Mutat; 2018 Apr; 39(4):579-587. PubMed ID: 29316027
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
6. Wiskott Aldrich Syndrome-2 Caused by Novel Wiskott Aldrich Syndrome Protein-Interacting Protein (WIP) Deficiency Is Associated with Juvenile Myelomonocytic Leukaemia - a Case Report.
Senthil S; Thrasher AJ; Gilmour KC; Wright T; Wynn RF
J Clin Immunol; 2023 Jan; 43(1):82-84. PubMed ID: 36169901
[No Abstract] [Full Text] [Related]
7. [Identification of two novel WASP gene mutations in 3 boys with Wiskott-Aldrich syndrome].
Jiang LP; Xu YH; Yang XQ; Liu EM; Wang LJ; Lau YL; Chan KW
Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):590-3. PubMed ID: 14744380
[TBL] [Abstract][Full Text] [Related]
8. Nonsyndromic Juvenile Myelomonocytic Leukemia With PTPN11 Mutation in a 9-Year-old Girl.
Sarper N; Gelen SA; Zengin E; Demirsoy U; Erçin C
J Pediatr Hematol Oncol; 2015 Aug; 37(6):486-7. PubMed ID: 26181421
[TBL] [Abstract][Full Text] [Related]
9. After 95 years, it's time to eRASe JMML.
Meynier S; Rieux-Laucat F
Blood Rev; 2020 Sep; 43():100652. PubMed ID: 31980238
[TBL] [Abstract][Full Text] [Related]
10. Wiskott-Aldrich syndrome/X-linked thrombocytopenia in China: Clinical characteristic and genotype-phenotype correlation.
Liu DW; Zhang ZY; Zhao Q; Jiang LP; Liu W; Tu WW; Song WX; Zhao XD
Pediatr Blood Cancer; 2015 Sep; 62(9):1601-8. PubMed ID: 25931402
[TBL] [Abstract][Full Text] [Related]
11. Gene mutations in the Ras pathway and the prognostic implication in Korean patients with juvenile myelomonocytic leukemia.
Park HD; Lee SH; Sung KW; Koo HH; Jung NG; Cho B; Kim HK; Park IA; Lee KO; Ki CS; Kim SH; Yoo KH; Kim HJ
Ann Hematol; 2012 Apr; 91(4):511-7. PubMed ID: 21901340
[TBL] [Abstract][Full Text] [Related]
12. Detection of six novel mutations in WASP gene in fifteen Iranian Wiskott-Aldrich patients.
Safaei S; Fazlollahi MR; Houshmand M; Hamidieh AA; Bemanian MH; Alavi S; Mousavi F; Pourpak Z; Moin M
Iran J Allergy Asthma Immunol; 2012 Dec; 11(4):345-8. PubMed ID: 23264413
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of clinical features and gene mutations in 6 patients with Wiskott-Aldrich syndrome].
Jiang MH; Wang ZY; Su J; Cao LJ; Li JQ; Sun XH; Bai X; Wang GF; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2011 Sep; 32(9):577-82. PubMed ID: 22338148
[TBL] [Abstract][Full Text] [Related]
14. Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia.
Locatelli F; Algeri M; Merli P; Strocchio L
Expert Rev Hematol; 2018 Feb; 11(2):129-143. PubMed ID: 29279013
[TBL] [Abstract][Full Text] [Related]
15. Novel WASP mutation in a patient with Wiskott-Aldrich syndrome: Case report and review of the literature.
Eghbali M; Sadeghi-Shabestari M; Najmi Varzaneh F; Zare Bidoki A; Rezaei N
Allergol Immunopathol (Madr); 2016; 44(5):450-4. PubMed ID: 26993433
[TBL] [Abstract][Full Text] [Related]
16. Juvenile myelomonocytic leukemia: who's the driver at the wheel?
Niemeyer CM; Flotho C
Blood; 2019 Mar; 133(10):1060-1070. PubMed ID: 30670449
[TBL] [Abstract][Full Text] [Related]
17. Juvenile myelomonocytic leukemia-associated variants are associated with neo-natal lethal Noonan syndrome.
Mason-Suares H; Toledo D; Gekas J; Lafferty KA; Meeks N; Pacheco MC; Sharpe D; Mullen TE; Lebo MS
Eur J Hum Genet; 2017 Apr; 25(4):509-511. PubMed ID: 28098151
[TBL] [Abstract][Full Text] [Related]
18. Lineage-dependent skewing of loss of heterozygosity (LOH) of KRAS gene in a case of juvenile myelomonocytic leukemia.
Tokuda K; Eguchi-Ishimae M; Iwabuki H; Kawakami S; Tauchi H; Ishii E; Eguchi M
Eur J Haematol; 2015 Feb; 94(2):177-81. PubMed ID: 24766281
[TBL] [Abstract][Full Text] [Related]
19. Wiskott-Aldrich Syndrome: Description of a New Gene Mutation With Normal Platelet Volume.
Yoonessi L; Randhawa I; Nussbaum E; Saharti S; Do P; Chin T; Zwerdling T
J Pediatr Hematol Oncol; 2015 Oct; 37(7):515-8. PubMed ID: 26241726
[TBL] [Abstract][Full Text] [Related]
20. In vitro expansion of CD34(+)CD38(-) cells under stimulation with hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia.
Sakashita K; Kato I; Daifu T; Saida S; Hiramatsu H; Nishinaka Y; Ebihara Y; Ma F; Matsuda K; Saito S; Hirabayashi K; Kurata T; Uyen LT; Nakazawa Y; Tsuji K; Heike T; Nakahata T; Koike K
Leukemia; 2015 Mar; 29(3):606-14. PubMed ID: 25102944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
